10x Genomics, Inc. Proceeds from Lines of Credit
10x Genomics, Inc. (TXG) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2022-02-18
- 10x Genomics, Inc. proceeds from lines of credit for the quarter ending 2020-12-31 was $0.00.
- 10x Genomics, Inc. proceeds from lines of credit for the quarter ending 2019-12-31 was $0.00.
- 10x Genomics, Inc. proceeds from lines of credit for fiscal 2021 was $0.00.
- 10x Genomics, Inc. proceeds from lines of credit for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- 10x Genomics, Inc. proceeds from lines of credit for fiscal 2019 was $11.00M.
- 10x Genomics, Inc. proceeds from lines of credit for fiscal 2018 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-18 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $0.00 10-K · filed 2022-02-18 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $11.00M 10-K · filed 2022-02-18 | |
| 2019-09-30 | $11.00M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |